Healius

Healius Launches National Pharmacogenomic Awareness Campaign

Healius' Genomic Diagnostics division has initiated a national awareness campaign for Pharmacogenomic (PGx) testing. The campaign aims to educate patients about the benefits of simple DNA tests, encouraging wider adoption of personalized medicine approaches within Australia. This initiative seeks to improve patient outcomes by tailoring treatments based on individual genetic profiles.

Healius Lumus Imaging announces Annalise.ai partnership for AI-driven diagnostics

Healius' Lumus Imaging division has announced a partnership with Annalise.ai, a leader in artificial intelligence for medical imaging. This collaboration aims to integrate advanced AI solutions into Lumus Imaging's operations, enhancing diagnostic accuracy and efficiency. The partnership is expected to improve patient outcomes by enabling faster and more precise interpretations of medical scans across Healius' network.